$MDT - Primed for the next leg upNYSE:MDT broke out from the channel and is consolidating in a flag. It looks primed for the next leg up. 🚀
Price targets:
$92
$96
$100
$104
Downside risk:
$76
2.92EUR
3.41 BEUR
28.35 BEUR
1.33 B
About MEDTRONIC PLC DL-,0001
Sector
Industry
CEO
Geoffrey Straub Martha
Website
Headquarters
Dublin
Employees (FY)
95 K
Founded
2014
ISIN
IE00BTN1Y115
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Stocks pairs trading: BMY vs MDTIn the medical device and pharmaceutical sectors, contrasting financial metrics and market dynamics between Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY) present a compelling scenario for investors. Based on their respective financial performances and market positions, it could be strat
MDT Medtronic plc Options Ahead of EarningsIf you haven`t bought the previous dip in MDT:
Then analyzing the options chain and the chart patterns of MDT Medtronic plc prior to the earnings report this week,
I would consider purchasing the 75usd strike price at the money Calls with
an expiration date of 2023-11-24,
for a premium of approxim
i.Wish $MDT keep going down furtherMDT has increased its dividend for 46 consecutive years. Easing supply-chain issues, new product launches, and higher demand for medical procedures have been supporting Medtronic’s performance.
In addition, the company is focusing on digital technology adoption and cost-saving measures, with a targ
$MDT - Can 200DMA provide a support?NYSE:MDT Ouch! A false break out and a fast breakdown. Lets see if 200DMA can provide some support. Otherwise, a trip down to $76 is possible. ER is on 22nd August. Its a make it or break it quarter. 👀
Argus Market Mover on 06/20/2023: MDTcopy & paste directly from Argus,
Medtronic is one of the world's largest medical technology and solutions companies. The company’s devices focus on cardiac rhythm management, spinal and surgical navigation technologies, treatments
for diabetes and neurological conditions, vascular therapies, and
$MDT - Looks goodNYSE:MDT Breaking out of the descending wedge with a ☕️.
If the stock can break above $92, it can run to $105. Breaking below $84 would be bearish. $89 - 92 is going to be a hard resistance to overcome.
Targets - $92, $100, $105
Downside risk - $76
$MDT with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:MDT after a negative over reaction following its earnings release placing the stock in drift D with an expected accuracy of 40%.
Campaign Trading Medtronic to the $130 zoneyep ... Medtronic has been taking advantage of A.I. for years.
"By harnessing the power of AI, data analytics, and sensors, Medtronic's healthcare technologies are helping clinicians create individualized treatment plans to achieve better outcomes for more people in more places. From the world’s fi
MDT is set to recover - overreaction on the outlookMDT beat analysts' estimates but guided somewhat dovish. The market has penalized the stock - it could be an overreaction. The management executes well on the business. I expect higher prices.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2M6 is 73.64 EUR — it has increased by 0.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on DUS exchange MEDTRONIC PLC DL-,0001 stocks are traded under the ticker 2M6.
MEDTRONIC PLC DL-,0001 is going to release the next earnings report on May 23, 2024. Keep track of upcoming events with our Earnings Calendar.
2M6 stock is 0.20% volatile and has beta coefficient of 0.97. Check out the list of the most volatile stocks — is MEDTRONIC PLC DL-,0001 there?
One year price forecast for MEDTRONIC PLC DL-,0001 has a max estimate of 97.96 EUR and a min estimate of 70.64 EUR.
2M6 earnings for the last quarter are 1.18 EUR per share, whereas the estimation was 1.12 EUR resulting in a 5.78% surprise. The estimated earnings for the next quarter are 1.17 EUR per share. See more details about MEDTRONIC PLC DL-,0001 earnings.
MEDTRONIC PLC DL-,0001 revenue for the last quarter amounts to 7.55 B EUR despite the estimated figure of 7.50 B EUR. In the next quarter revenue is expected to reach 7.35 B EUR.
Yes, you can track MEDTRONIC PLC DL-,0001 financials in yearly and quarterly reports right on TradingView.
2M6 stock has fallen by 3.71% compared to the previous week, the month change is a 4.26% fall, over the last year MEDTRONIC PLC DL-,0001 has showed a 4.54% decrease.
2M6 net income for the last quarter is 1.22 B EUR, while the quarter before that showed 859.75 M EUR of net income which accounts for 42.15% change. Track more MEDTRONIC PLC DL-,0001 financial stats to get the full picture.
Today MEDTRONIC PLC DL-,0001 has the market capitalization of 98.80 B, it has decreased by 3.46% over the last week.
Yes, 2M6 dividends are paid quarterly. The last dividend per share was 0.64 EUR. As of today, Dividend Yield (TTM)% is 3.49%. Tracking MEDTRONIC PLC DL-,0001 dividends might help you take more informed decisions.
MEDTRONIC PLC DL-,0001 dividend yield was 2.99% in 2022, and payout ratio reached 96.47%. The year before the numbers were 2.41% and 67.58% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 2M6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDTRONIC PLC DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 95.00 K employees. See our rating of the largest employees — is MEDTRONIC PLC DL-,0001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDTRONIC PLC DL-,0001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDTRONIC PLC DL-,0001 stock shows the sell signal. See more of MEDTRONIC PLC DL-,0001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDTRONIC PLC DL-,0001 future price: according to them, 2M6 price has a max estimate of 97.96 EUR and a min estimate of 70.64 EUR. Read a more detailed MEDTRONIC PLC DL-,0001 forecast: see what analysts think of MEDTRONIC PLC DL-,0001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDTRONIC PLC DL-,0001 EBITDA is 8.00 B EUR, and current EBITDA margin is 26.28%. See more stats in MEDTRONIC PLC DL-,0001 financial statements.